Organization (Academic)
Wonkwang University
ClinicalTrials.gov lists Wonkwang University as lead sponsor of 27 trials, counting the companies grouped under it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. Companies grouped under this one are not included. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 0 registered with a 2026 start date. The dashed outline is the pace from the 0 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
This page covers Wonkwang University and 1 company grouped under it: 27 lead-sponsored trials (1 its own, 26 in the grouped companies) and 2 legal-entity registrations (1 its own, 1 in the grouped companies).
Companies grouped under this page (1)
| Company | Lead trials | Legal entities |
|---|---|---|
| Wonkwang University Hospital | 26 | 1 |
Disease areas (48)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Pain | 5 |
| Coronary Artery Disease | 3 |
| Coronary Disease | 3 |
| Inflammatory Bowel Diseases | 3 |
| Stroke | 3 |
Showing 5 of 48 disease areas.
Trials by start year as sponsor or collaborator (12)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2019 | 1 |
| 2018 | 2 |
| 2017 | 1 |
| 2016 | 1 |
| 2015 | 1 |
| 2014 | 1 |
| 2013 | 1 |
| 2012 | 2 |
| 2011 | 1 |
| 2010 | 1 |
Showing 10 of 12 years.
Recruitment duration, a model prediction: none of the 1 trial evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Journals published in (76)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| Gastrointestinal endoscopy | 4 |
| Anesthesia and analgesia | 2 |
| Anesthesia and pain medicine | 2 |
| Archives of physical medicine and rehabilitation | 2 |
| BMJ open | 2 |
Showing 5 of 76 journals.
Organization relationships (49)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| Yonsei University | Co sponsors trial with | 7 |
| Seoul National University | Co sponsors trial with | 7 |
| Korea University | Co sponsors trial with | 4 |
| Samsung (South Korea) | Co sponsors trial with | 4 |
| Ewha Womans University | Co sponsors trial with | 4 |
Showing 5 of 49 relationships.
Latest dated events (52)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2026-07-02 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-07-02 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-07-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-07-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-07-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 52 events.
Biomarker capability evidence (6)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| FBRS | Trial collaborator | Named in trial exclusion criteria |
| FBXO8 | Trial collaborator | Named in trial exclusion criteria |
| GGT1 | Trial collaborator | Named in trial exclusion criteria |
| FBRS | Trial collaborator | Mentioned in trial text |
| FBXO8 | Trial collaborator | Mentioned in trial text |
Showing 5 of 6 evidence rows.
Biomarkers this organization publishes on (99)
Shown in this order: most publications first.
Showing 5 of 99 biomarkers.
Not on this page
Checked, with nothing recorded for this organization: related companies not grouped here, active development programs, approved assets, sponsor delivery record, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, and clia clinical laboratory certificates.